Sionna Therapeutics, Inc. (NASDAQ:SION) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Peter Kolchinsky Other companies: Freenome, Inc. (Director · Since at least Jul 20, 2026); Parabilis Medicines, Inc. (Director · Since at least Jun 9, 2026); Hemab Therapeutics Holdings, Inc. (Director · Since at least Apr 30, 2026); SpyGlass Pharma, Inc. (Director · Since at least Feb 5, 2026); Evommune, Inc. (Director · Since at least Nov 5, 2025); Septerna, Inc. (Director · Since at least Oct 24, 2024); Bicara Therapeutics Inc. (Director · Since at least Sep 12, 2024); Artiva Biotherapeutics, Inc. (Director · Since at least Jul 18, 2024); Cidara Therapeutics Inc (Director · Since at least Apr 24, 2024); LENZ Therapeutics, Inc. (Director · Since at least Mar 21, 2024); Mineralys Therapeutics, Inc. (Director · Since at least Feb 9, 2023); Acrivon Therapeutics, Inc. (Director · Since at least Nov 9, 2022); ARS Pharmaceuticals, Inc. (Director · Since at least Nov 8, 2022); PepGen Inc. (Director · Since at least May 5, 2022); Nkarta, Inc. (Director · Since at least Feb 14, 2022); Tyra Biosciences, Inc. (Director · Since at least Sep 14, 2021); Climb Bio, Inc. (Director · Since at least Aug 9, 2021); Acumen Pharmaceuticals, Inc. (Director · Since at least Jun 30, 2021); Janux Therapeutics, Inc. (Director · Since at least Jun 10, 2021); Vor Biopharma Inc. (Director · Since at least Feb 4, 2021); 89bio Inc (Director · Since at least Nov 8, 2019); Wave Life Sciences Ltd. (Director · Since at least Aug 14, 2015); Black Diamond Therapeutics, Inc. (Director · Jul 5, 2023 – Jul 5, 2023 · Past); Iteos Therapeutics Inc (Director · Jun 9, 2022 – Jun 9, 2022 · Past); Icosavax Inc (Director · Jul 28, 2021 – Feb 19, 2024 · Past); Cytek Biosciences, Inc. (Director · Jul 22, 2021 – Mar 14, 2022 · Past); Jade Biosciences, Inc. (Director · Jun 29, 2021 – Jun 17, 2024 · Past); Werewolf Therapeutics, Inc. (Director · Apr 29, 2021 – May 12, 2025 · Past); Research Alliance Corp II (Chief Executive Officer, Director · Mar 17, 2021 – Mar 17, 2021 · Past); Orchard Therapeutics PLC (Director · Feb 9, 2021 – Feb 9, 2021 · Past); Solid Biosciences Inc. (Director · Dec 10, 2020 – Jan 11, 2024 · Past); POINT Biopharma Global Inc (Chief Executive Officer, Director · Jul 7, 2020 – Jun 29, 2021 · Past); Forma Therapeutics Holdings Inc (Director · Jun 18, 2020 – Jun 8, 2022 · Past); Satsuma Pharmaceuticals Inc (Director · Sep 12, 2019 – Jun 3, 2022 · Past); Synthorx Inc (Director · Dec 6, 2018 – Jan 23, 2020 · Past); Kala Bio, Inc. (Director · Oct 3, 2018 – Mar 13, 2020 · Past); Eidos Therapeutics Inc (Director · Jun 19, 2018 – Jun 19, 2018 · Past); KalVista Pharmaceuticals, Inc. (Director · Oct 12, 2017 – Oct 12, 2017 · Past); Ra Pharmaceuticals Inc (Director · Jun 20, 2017 – Apr 2, 2020 · Past); Dicerna Pharmaceuticals Inc (Director · Jan 29, 2014 – Nov 27, 2019 · Past) | Director · Since at least Feb 6, 2025 |
| Rajeev M Shah Other companies: Freenome, Inc. (Director · Since at least Jul 20, 2026); Parabilis Medicines, Inc. (Director · Since at least Jun 9, 2026); Hemab Therapeutics Holdings, Inc. (Director · Since at least Apr 30, 2026); SpyGlass Pharma, Inc. (Director · Since at least Feb 5, 2026); Evommune, Inc. (Director · Since at least Nov 5, 2025); Septerna, Inc. (Director · Since at least Oct 24, 2024); Bicara Therapeutics Inc. (Director · Since at least Sep 12, 2024); Artiva Biotherapeutics, Inc. (Director · Since at least Jul 18, 2024); Cidara Therapeutics Inc (Director · Since at least Apr 24, 2024); LENZ Therapeutics, Inc. (Director · Since at least Mar 21, 2024); Mineralys Therapeutics, Inc. (Director · Since at least Feb 9, 2023); Acrivon Therapeutics, Inc. (Director · Since at least Nov 9, 2022); ARS Pharmaceuticals, Inc. (Director · Since at least Nov 8, 2022); PepGen Inc. (Director · Since at least May 5, 2022); Nkarta, Inc. (Director · Since at least Feb 14, 2022); Tyra Biosciences, Inc. (Director · Since at least Sep 14, 2021); Wave Life Sciences Ltd. (Director · Since at least Aug 16, 2021); Climb Bio, Inc. (Director · Since at least Aug 9, 2021); Acumen Pharmaceuticals, Inc. (Director · Since at least Jun 30, 2021); Janux Therapeutics, Inc. (Director · Since at least Jun 10, 2021); Vor Biopharma Inc. (Director · Since at least Feb 4, 2021); 89bio Inc (Director · Since at least Nov 8, 2019); Iteos Therapeutics Inc (Director · Jun 9, 2022 – Jun 9, 2022 · Past); Forma Therapeutics Holdings Inc (Director · Jun 8, 2022 – Jun 8, 2022 · Past); Icosavax Inc (Director · Jul 28, 2021 – Feb 19, 2024 · Past); Cytek Biosciences, Inc. (Director · Jul 22, 2021 – Mar 14, 2022 · Past); Jade Biosciences, Inc. (Director · Jun 29, 2021 – Jun 17, 2024 · Past); POINT Biopharma Global Inc (Director · Jun 23, 2021 – Jun 29, 2021 · Past); Werewolf Therapeutics, Inc. (Director · Apr 29, 2021 – May 12, 2025 · Past); Orchard Therapeutics PLC (Director · Feb 9, 2021 – Feb 9, 2021 · Past); Black Diamond Therapeutics, Inc. (Director · Jan 29, 2020 – Jul 5, 2023 · Past); Satsuma Pharmaceuticals Inc (Director · Sep 12, 2019 – Jun 6, 2023 · Past); Eidos Therapeutics Inc (Director · Jun 19, 2018 – May 27, 2020 · Past); Solid Biosciences Inc. (Director · Jan 25, 2018 – Jan 11, 2024 · Past); Kala Bio, Inc. (Director · Jul 19, 2017 – Jun 17, 2021 · Past); KalVista Pharmaceuticals, Inc. (Director · Nov 21, 2016 – Oct 12, 2017 · Past); Ra Pharmaceuticals Inc (Director · Oct 25, 2016 – Apr 2, 2020 · Past) | Director · Since at least Feb 6, 2025 |
| Peter Thompson Other companies: Aspen Neuroscience, Inc. (General Partner · Since at least Nov 2, 2026); Edgewise Therapeutics, Inc. (Chairman and Co-Founder · Since at least Mar 25, 2021); ARS Pharmaceuticals, Inc. (Director · Since at least Dec 3, 2020); Corvus Pharmaceuticals, Inc. (CO-FOUNDER · Since at least Mar 22, 2016); Janux Therapeutics, Inc. (Director · Jun 10, 2021 – Jun 14, 2022 · Past); Decibel Therapeutics Inc (Director · Feb 11, 2021 – Jun 17, 2022 · Past); PMV Pharmaceuticals, Inc. (Director · Sep 24, 2020 – Jun 2, 2021 · Past); Prevail Therapeutics Inc (Director · Jun 19, 2019 – Jan 22, 2021 · Past); Synthorx Inc (Director · Dec 6, 2018 – Jan 23, 2020 · Past); Principia Biopharma Inc (Director · Sep 13, 2018 – Sep 13, 2018 · Past); Alpine Immune Sciences Inc (Director · Jul 24, 2017 – May 18, 2024 · Past); Adaptimmune Therapeutics PLC (Director · Jan 1, 2016 – Jun 4, 2018 · Past); Sierra Oncology Inc (Director · Jul 15, 2015 – Jul 21, 2015 · Past); Anthera Pharmaceuticals Inc (Director · Feb 1, 2011 – May 8, 2012 · Past); Trubion Pharmaceuticals Inc (President and CEO, Director · Oct 17, 2006 – Aug 27, 2009 · Past) | Director · Since at least Feb 6, 2025 |
| Bruce Booth Other companies: Vigil Neuroscience Inc (Director · Since at least Jan 6, 2022); Kymera Therapeutics, Inc. (Co-Founder · Since at least Aug 20, 2020); Dianthus Therapeutics, Inc. (Director · Jun 20, 2018 – Jun 28, 2022 · Past); Tectonic Therapeutic, Inc. (Director · Jun 20, 2018 – Jun 6, 2023 · Past); Cogent Biosciences, Inc. (Director · Mar 28, 2018 – Jul 1, 2020 · Past); Viridian Therapeutics, Inc. (Director · Feb 13, 2017 – Jun 27, 2018 · Past); Larimar Therapeutics, Inc. (Director · Jun 18, 2014 – Jan 3, 2018 · Past) | Director · Since at least Feb 6, 2025 |
| Joshua Resnick Other companies: Cidara Therapeutics Inc (Director · Since at least Jan 3, 2025); PepGen Inc. (Director · Since at least May 5, 2022); Jade Biosciences, Inc. (Director · Jun 29, 2021 – Jun 5, 2024 · Past); Vor Biopharma Inc. (Director · Feb 4, 2021 – May 22, 2025 · Past); Tectonic Therapeutic, Inc. (Director · Jun 20, 2018 – Jun 20, 2018 · Past); KalVista Pharmaceuticals, Inc. (Director · Nov 21, 2016 – Sep 27, 2017 · Past) | Director · Since at least Feb 6, 2025 |
| Laurie Stelzer Other companies: MBX Biosciences, Inc. (Director · Since at least Jan 20, 2026); Spyre Therapeutics, Inc. (Chair of the Audit Committee · Since at least Nov 22, 2023); PMV Pharmaceuticals, Inc. (Chair, Board of Directors · Since at least Sep 24, 2020); Arena Pharmaceuticals Inc (EVP & Chief Financial Officer · Mar 16, 2020 – Mar 11, 2022 · Past); Surface Oncology Inc (Director · Apr 18, 2018 – Jun 8, 2022 · Past); Halozyme Therapeutics, Inc. (SVP, Chief Financial Officer · Jun 15, 2015 – Feb 22, 2020 · Past) | Director · Since at least Feb 6, 2025 |
| Paul J. Clancy Other companies: Xilio Therapeutics, Inc. (Director · Since at least Oct 21, 2021); EXACT Sciences Corporation (Director · Since at least Mar 18, 2021); Incyte Corporation (Director · Since at least Jan 20, 2015); Alexion Pharmaceuticals Inc (EVP, Chief Financial Officer · Jul 10, 2017 – Jul 11, 2019 · Past); Agios Pharmaceuticals, Inc. (Director · Sep 24, 2013 – Jun 21, 2022 · Past); Biogen Inc. (Executive VP and CFO · Aug 13, 2007 – Apr 25, 2017 · Past) | Chair · Since at least Feb 6, 2025 |
| Elena Ridloff Other companies: Immunic, Inc. (Independent Director · Since at least Aug 6, 2026); Kymera Therapeutics, Inc. (Director · Since at least Mar 12, 2021); Kronos Bio Inc (Director · Since at least Oct 8, 2020); ACADIA Pharmaceuticals Inc. (EVP and CFO · Mar 30, 2019 – Apr 29, 2021 · Past) | Chief Financial Officer & Chief Business Officer · Since at least Feb 6, 2025 |
| Joanne L Viney Other companies: LENZ Therapeutics, Inc. (Director · Jun 24, 2021 – Jul 19, 2023 · Past); Pandion Therapeutics Inc (See Remarks · Jul 16, 2020 – Apr 1, 2021 · Past); Harpoon Therapeutics Inc (Director · Jul 1, 2020 – Apr 1, 2023 · Past) | Director · Since at least Feb 6, 2025 |
| Lucian Iancovici Other companies: Achieve Life Sciences, Inc. (Chairman of the Board of Directors · Since at least Apr 17, 2026); Rallybio Corporation (Board Member · Since at least Jul 29, 2021); CeriBell, Inc. (Director · Oct 10, 2024 – Oct 10, 2024 · Past) | Director · Since at least Feb 6, 2025 |
| Harold Edward Fleming Other companies: Upstream Bio, Inc. (Director · Since at least Oct 10, 2024); CRISPR Therapeutics AG (Director · Since at least Jun 10, 2021) | Director · Since at least Feb 6, 2025 |
| Marcella Kuhlman Ruddy Other companies: Upstream Bio, Inc. (Chief Medical Officer, Tectonic Therapeutic · Since at least Oct 10, 2024); Tectonic Therapeutic, Inc. (Chief Medical Officer · Since at least Jun 20, 2024) | Director · Since at least Feb 6, 2025 |
| Michael Cloonan Other companies: Bluebird bio Inc (Director · Since at least Jun 20, 2024); Sage Therapeutics Inc (Chief Business Officer · Apr 24, 2017 – Feb 10, 2021 · Past) | President & CEO, Director · Since at least Feb 6, 2025 |
| Edd Fleming Other companies: Upstream Bio, Inc. (Executive Vice President, Enavate Sciences · Since at least Nov 5, 2026) | Director · Since at least Nov 5, 2026 |
| Josh Resnick Other companies: PepGen Inc. (Non-Executive Director · Since at least Nov 4, 2026) | Director · Since at least Nov 4, 2026 |
| Alison Easter | Vice President, Preclinical Safety · Since at least Nov 4, 2026 |
| Ashley Parks | Vice President, Chief of Staff to CEO and Program Lead · Since at least Nov 4, 2026 |
| Caroline Stark Beer | Chief Business Officer · Since at least Sep 8, 2025 |
| Cécile Le Camus | Vice President, Medical Affairs, Patient Advocacy, & Development Operations · Since at least Nov 4, 2026 |
| Charlotte McKee | Head of R&D & Chief Medical Officer · Since at least Feb 6, 2025 |
| Erica Iorio | Vice President, Finance and Controller · Since at least Nov 4, 2026 |
| Jen Fitzpatrick | Chief Legal Officer & Head of Program Management · Since at least Sep 18, 2026 |
| Jennifer Fitzpatrick | CLO and Head of Program Mgmt. · Since at least Apr 1, 2025 |
| Jo Viney | Director · Since at least Mar 20, 2025 |
| Mara Furlow | Senior Vice President, Global Regulatory Affairs and Quality · Since at least Nov 4, 2026 |
| Mark Trone | Senior Vice President, Head of Technical Operations · Since at least Nov 4, 2026 |
| Mike Cloonan | President and Chief Executive Officer · Since at least Sep 14, 2026 |
| Roxanne McGrath | Vice President, Head of Human Resources · Since at least Nov 4, 2026 |